ORKA compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ORKAOruka Therapeutics, Inc.

JBIOJade Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

Mkt cap$6.4B

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

ClosedOct 30 '26

Mkt cap$894.2M

Compare

ClosedOct 30 '26

ORKAOruka Therapeutics, Inc.

JBIOJade Biosciences, Inc.

96.24▼−0.42%post 98.76

Price

14.07▼−1.19%post 14.07

$6.4B

Mkt cap

$894.2M

ORKA96.24▼−0.42%vsJBIO14.07▼−1.19%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ORKA, solidJBIO, dashed

Supply-chain overlap

Revenue flow

ORKA: latest quarter not drawable. JBIO: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ORKA 0

None

Shared 0

No disclosed counterparties: ORKA.

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR